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While Botulinum NeuroToxin-A (BoNT-A) injections are frequently used to reduce the
effects of hyperactive stretch reflexes in children with cerebral palsy (CP), the effects
of this treatment vary strongly. Previous research, combining electromyography (EMG)
with motion analysis, defined different patterns of stretch reflex muscle activation in
muscles, those that reacted more to a change in velocity (velocity dependent –VD),
and those that reacted more to a change in length (length dependent –LD). The aim
of this study was to investigate the relation between the types of stretch reflex muscle
activation in the semitendinosus with post-BoNT-A outcome as assessed passively and
with 3D gait analysis in children with spastic CP. Eighteen children with spastic CP (10
bilaterally involved) between the ages of 12 and 18 years were assessed before and
on average, 8 weeks post-treatment. EMG and motion analysis were used to assess
the degree and type of muscle activation dependency in the semitendinosus during
passive knee extensions performed at different joint angular velocities. Three-dimensional
gait analysis was used to assess knee gait kinematics as a measure of functional
outcome. Pre-treatment, 9 muscles were classified as VD and 9 as LD, but no differences
between the groups were evident in the baseline knee gait kinematics. Post-treatment,
stretch reflex muscle activation decreased significantly in both groups but the reduction
was more pronounced in those muscles classified pre-treatment as VD (−72% vs.
−50%, p = 0.005). In the VD group, these changes were accompanied by greater
knee extension at initial contact and during the swing phase of gait. In the LD group,
there was significantly increased post-treatment knee hyperextension in late stance.
Although results vary between patients, the reduction of stretch reflex muscle activation
in the semitendinosus generally translated to an improved functional outcome, as
assessed with 3D gait analysis. However, results were less positive for those muscles
with pre-treatment length-dependent type of stretch reflex muscle activation. The study
demonstrates the relevance of categorizing the type of stretch reflex muscle activation
as a possible predictor of treatment response.
Keywords: cerebral palsy, stretch reflex, spasticity, gait analysis, Botulinum toxin, treatment, tone reduction,
muscle spindles
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INTRODUCTION
Cerebral palsy (CP) is a common childhood physical disability
caused by a non-progressive brain injury resulting in impaired
development of the musculoskeletal system (1). The most
common motor impairment among children with CP is
spastic paresis (2), in which hindered development of the
descending motor and sensory tracks results initially, in
muscle paresis, followed very quickly by muscle alterations
including increased sensitivity of the stretch reflexes (3, 4).
When stretch reflexes, as measured at rest, are exaggerated
in response to a changing stretch velocity, they are referred
to as “spasticity” (5). In addition, studies carried out
on different muscles of children with CP have reported
exaggerated stretch reflexes in response to changes in muscle
length, rather than velocity (6–9). In particular, length-
dependent stretch reflex activation was most prevalent in
the semitendinosus (6). Some hypothesize that this length-
dependency reflects more severely affected muscles (2) or
muscles with a more complex movement disorder (10).
While several underlying pathophysiological mechanisms
of the different types of stretch reflex muscle activation
have been proposed (2), it is also relevant to verify whether
treatment response differs between the two types of stretch
reflex activation.
Reduction of hyperactive stretch reflexes is a key component
of the therapy directed at children with spastic CP. For
example, injections of Botulinum NeuroToxin-A (BoNT-A)
to the semitendinosus are commonly included in a multi-
level therapy approach (11). However, treatment success
following BoNT-A injections varies strongly, especially in
proximal leg muscles, such as the semitendinosus (12).
This response variability necessitates more research to help
delineate to whom such treatment should be directed. This is
especially important given the concerns regarding the possible
longitudinal impact of repeated BoNT-A injections on muscle
growth (13, 14).
Instrumented assessments such as electromyography (EMG)
and 3D motion analysis are becoming more accessible in
clinical settings. Compared to ordinal clinical scales, these
instruments allow more accurate diagnosis of impairments in
children with CP, leading to more informed treatment decisions.
In addition, given the low correlation between impairments
assessed with the child at rest on an examination table
and their assessment during gross motor function, such as
gait, it is important that treatment effects are assessed in
an instrumented way in both passive and active conditions
(15). Therefore, using EMG and motion analysis during
passive stretch and during gait, the aim of this study was to
examine whether the type of stretch reflex muscle activation
affects treatment outcome after BoNT-A injections in the
semitendinosus of children with spastic CP. We hypothesized
that those muscles with pure velocity-dependent reflexes
pre-treatment will show greater improvement post BoNT-A




Ethical approval was granted by the University Hospitals’ Ethics
Committee (B32220072814). Parents/guardians and subjects
were informed of the procedure. Parents/guardians and children
over the age of 12 provided written informed consent in
accordance with the Declaration of Helsinki.
Participants
A convenience sample of 19 children with spastic CP aged 12–
18 years were included (Table 1). Data from the instrumented
spasticity assessment, but not their gait analysis, had also been
analyzed for a previous study (16). One child from this sample did
not undergo a gait analysis on the same day as the instrumented
spasticity assessment and was therefore excluded from the
current study, resulting in 18 subjects for final analysis. The
exclusion criteria were as previously reported: a diagnosis (by
a neurologist) of ataxia or dystonia; severe muscle weakness
[<2+ on the Manual Muscle Test (17)]; poor selectivity (18);
knee joint contractures that compromised passive knee joint
motion to <20 degrees; cognitive problems that could impede
the measurements; previous lower-limb orthopedic surgery;
intrathecal baclofen pump; selective dorsal rhizotomy; BoNT-A
injections 6 months prior to the first assessment.
Treatment
Subjects received BoNT-A injections in the semitendinosus as
part of a multilevel treatment. BoNT-A dosage and muscle
selection were based on patient weight, medical history, findings
of a clinical examination, and 3D gait analysis. Injection was
done under short general anesthesia, and ultrasound was used
for visual identification of muscles and needle depth control
(19). As part of the established and standardized integrated
approach for BoNT-A treatment at the University Hospital, all
patients received some casting during 1–2 weeks immediately
following the injections. Some children only had ankle casting
(i.e., below-the-knee), while for other children the ankle casts
were combined with removable or non-removable full leg casts
and an additional abduction-exorotation bar. As part of their
regular care, physiotherapy was intensified during the first 4
weeks post-treatment such that three to five sessions of 30–
60min physiotherapy were provided per week. Details of the
treatments are reported in Table 2.
Data Collection and Processing
3D Gait Analysis
Three-dimensional gait analysis data were collected using a
12 camera VICON system, operating at 100Hz (VICON,
Oxford Metrics, Oxford, UK). Fifteen reflective markers were
placed at specific anatomical landmarks on the pelvis and
lower limbs, according to the lower-limb Vicon Plug-in-Gait
marker configuration (VICON, Oxford Metrics, Oxford, UK).
All children walked barefoot at a self-selected walking speed
along the walkway. A trial was considered successful when there
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TABLE 1 | Included subject characteristics.
Pre-treatment stretch reflex activation
All (n = 18) Velocity dependent (n = 9) Length dependent (n = 9)
Mean age (SD) (years) 9.78 (1.87) 9.65 (1.77) 9.89 (2.07)
Male/female (n) 12/6 6/3 6/3
Bilateral involvement (n) 11 4 7
Unilateral involvement (R/L) (n) 3/4 3/2 1/1
GMFCS (I/II/III) (n) 6/8/4 5/3/1 1/5/3
Median (range) number of previous
BoNT-A injections in the medial
hamstrings (semitendinosus,
semimembranosus, gracilis)
2 (0–9) 2 (0–9) 0 (0–5)
GMFCS, gross motor functional classification scale; BoNT-A, botulinum neurotoxin-A.
TABLE 2 | Treatment details: number of injected muscles, average amount (SD) of Botulinum neurotoxin-A (botox®) injected per muscle, number of subjects prescribed
with upper leg casts and number of lower and/or upper-leg casts, average number of casting days, physiotherapy sessions per week and duration.
Pre-treatment stretch reflex activation pattern
All (n = 18) Velocity dependent (n = 9) Length dependent (n = 9)
botox® n Units/kg n Units/kg n Units/kg
Psoas 13 1.85 (0.55) 6 1.50 (0.55) 7 2.14 (0.38)
Adductor 7 1.21 (0.57) 3 0.83 (0.29) 4 1.5 (0.58)
Rectus femoris 3 1.0 (0.50) 2 1.00 (0.71) 1 1.0 (0.0)
Medial hamstrings (semitendinosus,
semimembranosus, gracilis)
18 4.44 (1.09) 9 4.32 (0.97) 9 4.56 (1.24)
Gastrocnemius 13 3.04 (1.33) 7 2.93 (1.64) 6 3.17 (0.98)
Soleus 8 1.91 (0.63) 4 1.69 (0.63) 4 2.13 (0.63)
Casting n Days in casts n Days in casts n Days in casts
Removable upper-leg casts 13 12.67 (1.97) 7 12.50 (2.07) 6 13.00 (2.00)
Non-removable upper-leg casts 4 2 2
No upper-leg casts 1 0 1
Non-removable lower-leg casts 16 9 7
Physiotherapy Sessions/week Session duration (min) Sessions/week Session duration (min) Sessions/week Session duration (min)
4.72 (2.37) 36.94 (12.14) 4.44 (1.01) 37.22 (11.74) 5.00 (3.28) 36.67 (13.23)
was good marker visibility. At least three successful trials were
collected per participant.
Gait cycle events of initial contact and toe-off were visually
determined in Nexus, Vicon (Oxford Metrics Group, UK) which
was also used to apply the lower limb Plug-in-Gait for extracting
3D kinematic data. Further analysis was only carried out on
the sagittal plane knee kinematics of the most affected knee
organized in gait cycles. Firstly, statistical analyses of the entire
kinematic waveforms were carried out in order to identify
those phases of the gait cycle that significantly differed pre-
post intervention. Secondly, the minimum knee extension angles
during stance and during swing were calculated. These angles
were previously found to be sensitive to treatment with BoNT-A
in the semitendinosus (12), and to spasticity (20).
Instrumented Assessments During Passive Stretch
The degree and type of stretch reflex activation in the
semitendinosus and its effect on passive knee extension
was assessed by combining surface EMG, inertial measurement
units and a hald-held dynamometer via a custom-built modular
measurement system (compactRIO, National Instruments,
Austin, Texas). The method has been extensively validated for
use in children with CP, proving reliable and sensitive to the
effects of BoNT-A (16, 21).
In childrenwith unilateral CP, only the affected side was tested.
In children with bilateral involvement, themost involved side was
tested. The most involved side was defined as the side with the
highest Modified Ashworth Scale score in the hamstrings (22)
or, in case of symmetrical scores, an earlier knee catch angle as
defined by the Modified Tardieu Scale (23). When sides were
equally affected, the left side was selected. Patients lay supine and
were instructed to relax. Circular Ag/AgCl electrodes (diameter
of 2 cm) were placed on the muscle bellies of the semitendinosus
and the rectus femoris, on specific landmarks with an inter-
electrode distance of 2 cm according to the SENIAM guidelines.
To minimize cable related movement artifacts on the EMG
signal, EMG cables and receivers were taped to the skin. EMG
data were collected using the Zerowire system (Cometa, Milan,
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IT) at a sample rate of 2000Hz. EMG recording were first
collected at rest to define baseline activity. With the knee and hip
stabilized by the examiner at 90 degrees, children were asked to
carry out three repetitions of an isometric maximum voluntary
contraction (MVC) with the knee flexors. The average recorded
EMG data from the semitendinosus during the MVCs were used
for normalization purposes of passive stretch EMG data collected
pre-treatment. Since BoNT-A influences the EMG amplitude, the
MVC pre- and post-treatment are not comparable. Therefore,
much care was given to standardize the location of the EMG
sensors, and EMG was not normalized post-treatment and when
comparing pre to post-treatment.
Following the MVCs, the knee joint was passively moved
by an examiner from knee flexion to full knee extension (from
here on referred to as stretch trials). Firstly, the stretch was
carried out at low velocity during ± 5s, then at an intermediate,
medium velocity during ± 1s, and finally at high velocity,
which was performed as fast possible. Three repetitions were
carried out at each velocity. Repetitions were separated by 10 s
intervals in order to avoid post-activation depression of the
electrophysiological response to stretch (24).
A 6th order zero-phase Butterworth bandpass filter ranging
from 20 to 500Hz was applied to the raw surface EMG signal.
The EMG envelope was extracted by taking the square root after
applying a low-pass 30Hz 6th order zero-phase Butterworth filter
on the squared raw signal. Joint position and joint velocity were
estimated from the data collected with the inertial measurement
units using a Kalman smoother (25). From this, joint range of
motion (ROM) and maximum angular velocity were obtained.
All angular velocity-time profiles were bell-shaped. By visualizing
the raw and processed data in a custom-made Matlab GUI,
stretch repetitions were excluded when performed out of plane
[see Supplement 1 in (21)], at inconsistent velocities between
different repetitions within a velocity trial (difference of >5, 15,
or 30◦/s for low, medium, and fast stretch trials, respectively),
in case of poor quality EMG (loss of signal, low signal-to-
noise ratio or obvious artifacts), or in case of unexpected
antagonist activation.
Stretch reflex sensitivity is related to the conditions
from which the stretch is performed, including starting
muscle length, stretch velocity and baseline muscle tone
(26). To check whether these parameters were equal across
groups and sessions, EMG recordings collected at rest,
the average starting knee angular positions and maximum
angular velocities from slow and fast stretch trials, and
the average knee joint ROM from slow stretch trials,
were extracted.
To quantify the amount of muscle activation during stretch,
we studied the area under the EMG envelope relative to the
position moved during stretch trials:
(1)integral EMG envelope =
∫ t1
t2
EMGenvelope (t ) dt
(2)average EMG envelope =
integral EMG evelope
t2 − t1
Where t1 and t2 are times corresponding to particular joint
positions. Length-dependent muscle activation, termed EMGLD,
was expected to increase between the start and end of the slow
stretch trials. Therefore, EMGLD was calculated from slow stretch
trials as the average EMG envelope during 60–90% ROM minus
the average EMG envelope during 10–30% ROM. The extremes
of the ROM (0–10 and 90–100%) were excluded as they were
more likely influenced by the performance of the examiner and
the comfort of the patient. EMGLD was then expressed as a
percentage of the pre-treatment average EMG envelope during
the MVCs. Muscles with EMGLD values ≥5%, were categorized
as length-dependent (LD) andmuscles with EMGLD values<5%,
as velocity-dependent (VD). Examples are provided in Figure 1.
In addition, the influence of increasing muscle stretch velocity
on EMG amplitude was quantified using data from both the
slow and the fast stretch trials. Specifically, the average EMG
envelope during fast trials was computed over a time interval
starting 200ms prior to the time corresponding to maximum
angular velocity and ending at the time corresponding to 90%
of the ROM. Then, the average EMG envelope in the time
interval corresponding to 10–90% ROM of the slow stretch trials
was deducted from this value. This parameter is referred to
as EMGVD, and was calculated for all muscles, irrespective of
categorization as LD or VD.
After accounting for the forces caused by gravity and inertia
[based on estimates of the lower leg weight (27)], the net knee
torque applied by the examiner was calculated from the external
forces, moments, and measured moment arms [Figure 1B in
(21)]. The (compensated) knee torque at 70 degrees knee flexion
(an angle that corresponded to the overall mid-ROM of all
subjects), further referred to as “Torque,” was computed and the
average value during slow stretch trials deducted from that during
fast stretch trials. All data processing, visualization and analyses
were carried out with custom-made MATLAB software (version
8.5.0 R2015a).
Statistical Analysis
Distribution normality of the data, divided by LD andVD groups,
was assessed with Shapiro-Wilik tests and by inspection of q–q
plots. Pre-treatment data were compared between LD and VD
groups, while analysis of the effect of treatment was carried out
separately for LD and VD groups as well as on the entire sample.
Firstly, the knee kinematic waveforms in the sagittal plane during
gait were compared with two-tailed unpaired (LD vs. VD) and
paired (pre-post treatment) tests using a statistical parametric
(SPM{t}) or non-parametric (SnPM{t}) map, over the gait cycle
data (28). The minimum knee extension angles during stance
and during swing were calculated per gait cycle and averaged
per individual.
Discrete parameters (from passive stretch trials and gait)
pre-treatment as well as the pre-post treatment change values
were compared between LD and VD groups using unpaired t-
tests or Mann Whitney U tests. Per group, as well as for the
entire group, the effect of treatment on all discrete parameters
(from passive stretch and gait) were carried out using paired
t-tests or Wilcoxon Signed rank tests. Data of the groups
were then combined to explore the relations between pre-post
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FIGURE 1 | Examples of velocity- and length-dependence of the stretch reflexes in the semitendinosus. The average normalized EMG envelope collected from the
semitendinosus during passive knee extensions is shown across equally spaced zones of the range of motion (P1-3) at low, medium and fast stretch velocities. In the
velocity-dependent activation pattern, EMG increases with increasing stretch velocity, but not across position zones. In the length-dependent activation pattern, EMG
increases with stretch velocity and across position zones.
treatment changes in passive stretch parameters with changes
in discrete gait parameters using either Pearson or Spearman
correlation coefficients.
For all tests, the significance was corrected for multiple testing
[p < 0.025 according to pcritical = 1–(1–α)
1/N (29)]. In addition
to significance, pre-post treatment change values had to be
larger than the minimal detectable change values extracted from
previous reliability analyses on similar samples (21, 30). All
statistical analyses were carried out using SPSS (IBM Statistics 24)
and custom-made scripts in MATLAB (version 8.5.0 R2015a).
RESULTS
Subjects and Treatments
Included subject characteristics are reported in Table 1. Nine
semitendinosus muscles were classified pre-treatment as having
VD and nine as LD pattern. Children classified with VD patterns,
tended to have a greater number of previous BoNT-A injections
compared to those classified with LD patterns. Assessments were
performed on average 59 ± 13 days after BoNT-A treatment.
On average, 4.4 ± 1.0 units/kg BoNT-A were injected in the
medial hamstring muscles (semitendinosus, semimembranosus
and gracilis). Other muscles that received treatment are listed in
Table 2. Post BoNT-A, the children wore lower and/or upper leg
casts for an average of 12.67 ± 1.97 days (ranging from 10 to
14 days).
Gait Analysis
The children’s knee kinematic waveforms before and after
treatment together with age-related normative database of
the gait laboratory (gray bands) are displayed in Figure 2.
There were no significant differences in the pre-treatment
knee kinematic gait curves between children with pre-treatment
VD and LD muscles (Figure 2A). On the other hand, post-
treatment, children categorized with an LD pattern showed
significantly greater knee extension from mid- to terminal
stance (Figure 2B). Those children with a pre-treatment VD
pattern indicated greater post-treatment knee extension at
initial contact, mid-stance and swing (Figure 2D). Comparison
of the discrete gait parameters per group can be found
in Table 4.
Instrumented Assessments During Passive
Stretch
EMGLD pre-treatment in those muscles categorized as LD was
45% higher than those muscles categorized as VD, indicating
correct group allocation. In addition, pre-treatment EMGVD was
about 2-fold in muscles categorized as VD compared to LD.
On the other hand, the pre-treatment baseline average EMG
envelope, starting angular positions, ROM, and applied stretch
velocities were not different between groups (Table 3).
Post-treatment results are reported in Table 4. Passive ROM
significantly increased only in the VD group (+18%), while joint
torque significantly decreased for the whole group (−30%) and
for the LD group (−44%), but not for the VD group (−13%).
EMGLD significantly decreased in the whole group (−53%)
and in the LD group (−68%), but tended to increase, though
not significantly, post-treatment in the VD group. EMGVD
significantly decreased post-treatment by 60% for the whole
group, and the reduction was significantly greater for the VD
compared to LD group (−72% vs. −50%, p = 0.005). Significant
positive correlations were found between the reduction in
EMGVD and increased knee extension at terminal swing (r =
0.61, p= 0.021).
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FIGURE 2 | Knee kinematics in the sagittal plane vs. normalized gait cycle and results of the statistical parametric mapping (SPM): (A) pre- and (B) post-treatment
velocity vs. length-dependent muscles; (C) pre- vs. post-treatment for the length dependent muscles; and (D) pre- vs. post-treatment for the velocity dependent
muscles. Gray curves are from a representative database of typically developing children.
DISCUSSION
In this study, we evaluated the outcome of BoNT-A treatment
in the semitendinosus in children with CP on the impairment
and activity level. We tested the hypothesis that the type of pre-
treatment hyper-activation of tonic stretch reflexes during passive
stretch (being velocity- or length-dependent) affects the outcome.
With the exception of highly trained athletes (31), a very high
stretch velocity is needed to activate a tonic stretch reflex in a
healthy relaxed muscle. In contrast, in subjects with an upper
motor neuron lesion diagnosed with spasticity, this threshold
is markedly reduced as stretch reflexes are hyperactive (32).
Clinically, this results in an exaggerated velocity-dependent
resistance to passively imposed movement about a joint (33).
However, studies have reported that very low velocity joint
rotations (<10–35 degrees/s) may already elicit a response in
subjects diagnosed with spasticity (34). This would imply that
in some cases, mechanisms other than velocity-dependency are
at work when a muscle involuntarily contracts in response to
an externally applied stretch. Furthermore, the dependency on
velocity and/or length has been described as beingmuscle, subject
and pathology-dependent (6, 7, 35). The current study is the
first to report that, at least in the semitendinosus muscles of
children with CP, the presence of length-dependent activation of
tonic stretch reflexes helps characterize response to focal tone-
reduction treatment. Those semitendinosus muscles with more
length-dependency tended to react less favorably to treatment as
assessed passively and during gait.
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TABLE 3 | Average (and standard deviation) values of pre-treatment parameters in velocity-dependent and length-dependent muscles from the instrumented
assessments during passive stretch.
Pre-treatment stretch reflex activation pattern
Passive stretch parameters Velocity dependent (n = 9) Length dependent (n = 9) p-value
Starting position slow (deg) 114.9 (9.7) 118.2 (7.1) 0.419
End position slow (deg) 43.8 (10.5) 43.0 (8.0) 0.849
Starting position fast (deg) 115.9 (8.6) 118.9 (6.2) 0.400
End position fast (deg) 37.6 (6.8) 43.6 (9.9) 0.165
Max velocity slow (deg/s) 23.2 (3.5) 25.9 (7.3) 0.358
Max velocity fast (deg/s) 293.5 (29.8) 261.4 (33.2) 0.049
ROM slow (deg) 70.0 (6.8) 75.7 (12.6) 0.315
Torque (Nm) 8.6 (3.8) 9.1 (3.2) 0.752
Baseline EMG during slow stretch trials (%MVC) 2.6 (1.7) 7.7 (9.5) 0.065
Baseline EMG during fast stretch trials (%MVC) 2.8 (2.0) 8.4 (10.5) 0.067
EMGLD (%MVC) 1.6 (1.6) 21.6 (23.8) 0.012
EMGLD (µV) 2.2 (2.4) 15.8 (7.0) <0.001
EMGVD (µV) 25.7 (12.2) 11.6 (5.2) 0.019
Max, maximum; ROM, range of motion; EMG, electromyography; MVC, maximum voluntary contraction; EMGLD, length dependent activation; EMGVD, velocity dependent activation.
p < 0.025.
TABLE 4 | Average and standard deviation values of parameters from the instrumented assessment during passive stretch and from the knee gait kinematics in the
sagittal plane during gait pre- and post-treatment.
All muscles (n = 18) Velocity dependent (n = 9) Length dependent (n = 9) (VD vs. LD change)
Pre Post p-value Pre Post Change p-value Pre Post Change p-value p-value
Passive stretch parameters
ROM slow (deg) 72.9 (10.5) 79.2 (8.0) 0.210 70.0 (6.8) 82.7 (6.0) 12.7 (10.4) 0.011 75.2 (12.6) 76.4 (8.6) 1.2 (9.0) 0.683 0.023
Torque (Nm) 8.9 (3.5) 6.0 (3.4) 0.003 8.6 (3.8) 7.0 (3.1) 1.6 (2.5) 0.107 9.1 (3.2) 5.2 (3.5) 4.0 (2.7) 0.001 0.077
EMGLD (µV) 9.8 (8.7) 4.6 (4.2) 0.366 2.2 (2.4) 4.5 (4.4) −2.2 (4.5) 0.205 15.8 (7.0) 4.7 (4.3) 11.2 (6.5) <0.00 < 0.001
EMGVD (µV) 17.9 (11.3) 6.1 (3.8) 0.002 25.7 (12.2) 7.3 (3.8) 18.4 (8.9) 0.012* 11.6 (5.2) 5.3 (3.8) 6.6 (5.1) 0.003 0.002*
Gait analysis parameters
Min knee angle in stance (deg) 9.5 (8.1) 5.3 (8.3) 0.008 12.2 (8.9) 7.2 (7.7) 5.1 (6.5) 0.066 6.8 (6.8) 3.4 (9.0) 3.4 (5.1) 0.069 0.579
Min knee angle at terminal
swing (deg)
27.7 (9.4) 24.1 (9.5) 0.026 27.6 (10.1) 21.1 (10.9) 6.5 (5.3) 0.012* 27.8 (9.2) 27.1 (7.5) 0.7 (5.0) 0.707 0.041
LD, length dependent; VD, velocity dependent. *Wilcoxon’s signed rank test for non-normally distributed data. p < 0.025.
In children with CP, spasticity in the semitendinosus is
thought to restrict knee extension at terminal swing, resulting in
reduced step length and excessive knee flexion at initial contact
(36, 37). In accordance, pre-treatment, the knee kinematic
gait pattern of the children included in the current study
had excessive knee flexion in the second half of swing and
during the first 10% of stance (Figure 2A). Flexion at these
time points was slightly more exaggerated in those children
categorized as having VD semitendinosus muscles, but the
differences were not significant. Post-treatment, improvements
of the knee angle at initial contact and terminal swing were only
significant in those children with pre-treatment VD patterns.
In contrast, post-treatment, children with LD patterns indicated
knee angles approaching hyperextension in stance, as well as
reduced and delayed knee flexion during swing. This pattern was
also evident pre-treatment in the LD group, but was even more
noticeable post-treatment.
In an extensive review of the effects of BoNT-A on gait in
children with CP, Nieuwenhuys et al. (12) reported that increased
knee extension in stance, similar to that observed in our LD
group, was the only significant effect at the level of the knee. If
our findings are confirmed, lack of reported response in other
critical gait phases such as initial contact and swing in the studies
included in the review, may have been due to the inclusion of
children with LD, rather than VD muscles.
Furthermore, knee hyper-extension at terminal stance is not
desirable and may be indicative of remaining gastrocnemius
spasticity resulting in a pathological plantarflexion knee
extension couple (38). While LD is less common in the
gastrocnemius than in the semitendinosus (6), it may be possible
that those subjects with LD semitendinosus muscles also have
LD activation of their gastrocnemius and therefore reduced
treatment effects. Another possibility for knee hyperextension
at terminal stance is quadriceps weakness. This suggests
that it may be worthwhile to explore possible differences in
underlying muscle strength between LD and VD muscles. If
LD muscles are indeed weaker, it may be hypothesized that
the benefits of tone reduction do not outweigh the loss of
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muscle strength. Alternatively, LD muscles may potentially
benefit from additional strength training to outbalance the loss
of muscle strength caused by treatment.
Although positive treatment response as assessed during
passive stretch was evident in both groups, the reduction in
EMGVD was significantly greater in those muscles with a pre-
treatment VD categorization. This reduction was associated with
an improved knee angle at terminal swing, confirming that
treatment of hyperactive tonic stretch reflexes improved the
children’s gait pattern, in particular in those subjects categorized
as having muscles with VD patterns.
Unexpectedly, muscles categorized as LD, rather than VD,
demonstrated a reduction in the torque measured during passive
stretch. This parameter was calculated by subtracting the torque
measured during low velocity stretch from that during fast stretch
at a given joint angle (70 degrees knee flexion). Therefore, a
change in joint angle, rather than torque also determines the
outcome of this parameter. Since ROM improved in the VD
group, the lack of significant reduction in torque at 70 degrees
knee flexion in the VD group may be a result of a changing joint
angle-moment relationship.
Pre-treatment values of EMGLD helped categorize subjects
into activation patterns. Therefore, EMGLD was not included
in the estimation of treatment response. Furthermore, given
the definition of spasticity as velocity-dependent, changes in
EMGLD were not deemed directly meaningful to judge the effect
of BoNT-A. Nevertheless, it was expected that BoNT-A results
in general muscle paresis. This was indeed confirmed, since
EMGLD in muscles categorized as LD decreased significantly
post-treatment. It is surprising however, that in VD muscles,
the opposite effect was observed, i.e., EMGLD tended to increase
post-treatment. Yet, this increase was not significant and values
were marginal to measurement errors reported from similar
samples (21).
Limitations
The current study is not without significant limitations. Firstly,
the study sample was small and heterogeneous, which did
not allow us to explore more between-group differences. In
particular, there were slightly more children classified as GMFCS
level 1 in the VD group. Therefore, the distinction of the groups
based on activation dependency alone, should be interpreted
as preliminary. Additionally, previous studies included mixed
forms of length and velocity dependency (6, 7). Such a mixed
form is also evident in the LD example of Figure 1. Here,
LD activation during slow and medium velocity stretch trials
increases with increasing muscle length. Yet, this is not the
case at fast velocity. This suggests an interaction between length
and velocity dependent activation. While the current study is
underpowered to do so, it may be interesting to further analyze
the significance of these mixed patterns.
Secondly, while we refer to the semitendinosus only,
its activity cannot actually be separated from that of the
semimembranosus with surface EMG. Similarly, other muscles
crossing the knee may have influenced the assessment of ROM
and the calculation of net joint torque. Thirdly, some of the
variation in post-treatment knee flexion during gait may be
ascribed to the multilevel BoNT-A treatment and not by solely
targeting the semitendinosus. Nevertheless, selected muscles and
dosages were similar between groups (Table 2). Some subjects
in the current study were also prescribed long-leg removable
casts post- BoNT-A injection. While the number of children
who received this were equally distributed among the groups,
we are missing information regarding post-treatment cast
adherence which may possibly have also influenced the results.
Similarly, while all children received standardized post-treatment
physiotherapy according to our hospital recommendations,
we cannot exclude the possible effects of physiotherapy on
treatment success.
Possible Etiology of Length and
Velocity-Dependent Activations
The etiology behind why some muscles are more length,
rather than velocity-dependent is unknown and beyond the
investigations of the current paper. Nevertheless, there are some
possibilities that may be considered.
Biomechanical Orientation
During passive muscle lengthening, motor neuron activation
will be defined by excitation of different receptors: muscle-
velocity sensing group Ia afferents, mono- and di-synaptic group
II afferents that respond to a muscle’s actual length, and poly-
synaptic receptors from cutaneous mechanoreceptors, joint and
tendon afferents. How and which sensors respond depends on
the muscles starting lengths, morphological properties, stiffness,
orientation of muscle fibers with regard to its tendon, as well as
spinal and supraspinal control. Moreover, these characteristics
are initially defined by posture and the muscles position within
the limb. For example, studies have indicated biomechanical
relationships between stretch reflex activation and starting
muscle lengths (26, 39, 40). In the current study however, starting
posture and joint orientation were similar between subjects and
can therefore not explain the observed differences in activation
thresholds between LD and VD muscles.
Muscle Properties
Compared to typically developing children, marked
morphological alterations have been reported in the semi-
tendinosus of children with CP, including smaller and shorter
muscle bellies, and shorter fascicles that result in an altered
moment-angle relationship (41). Short, stiff muscles may activate
sooner as information is relayed more efficiently between fibers
(3). Evidence for this has been reported in the elbow flexors
of stroke survivors and in the medial gastrocnemius muscles
of children with spastic CP, where muscle activation during
slow passive joint rotation was related to reduced absolute fiber
length (39) and reduced muscle lengthening (42). Therefore,
it is likely that altered intrinsic muscle properties in CP are
partly responsible for lowered activation thresholds during
passive stretch.
In many studies examining muscles affected by spasticity in
the passive state, EMG activation during low-velocity passive
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joint rotation is regarded as indicating lack of muscle relaxation,
and the data is discarded (4, 41, 43). We are fairly confident
that the data presented in the current study did not reflect active
participation by the subject. We were rigorous in monitoring
both agonist and antagonist muscles during the passive stretch
trials and carefully inspected the timing of any activation.
Therefore, data were only selected from stretch trials where
activation at low velocity gradually increased over the ROM.
Our findings suggest that, rather than disregarding this data,
capturing it may help identify children who require a different
treatment approach.
Treatment History
There are concerns in the clinical community that repeated
treatments with BoNT-A may irreversibly affect muscle volume
and quality. If the hypothesis mentioned in the previous
paragraph (i.e., that shorter, stiffer and more atrophied muscles
elicit earlier stretch reflexes and thus LD patterns) is true, then it
may be expected that those children with LD patterns would have
undergone a larger number of previous treatments with BoNT-
A. However, in our study, children with VD semitendinosus
muscles tended to have a larger number of previous treatments
with BoNT-A. Therefore, the suggestion that repeated BoNT-A
detrimentally affects muscle integrity is not directly supported
by our results. Rather, our finding that children with VD
patterns more often underwent BoNT-A injections may reflect
an appropriate subject selection and clinical decision-making.
However, these are assumptions that need to be verified in future
research. Given ongoing concern (14), careful monitoring of the
long term effects of BoNT-A in children with CP is paramount.
Baseline Tone
Recently, it has been suggested that muscle spindle firing
is modulated by fiber force, secondary to history-dependent
features. In other words, muscles that are pre-activated (for
example, when sustaining a standing posture) fire more strongly
as reaction to stretch than when fully relaxed (44). In a
simulation study, De Groote et al. (45) found an interaction
effect between baseline tone (indicating higher intrinsic muscle
force) and a reduced knee oscillation pattern when a leg with
spasticity was simulated to undergo a pendulum test. Therefore,
a possible explanation for a reduced activation threshold in
some spastic muscles may be a higher resting muscle tone
resulting in increased force detection by the spindles. Supporting
this theory, in the current study, the baseline resting average
EMG envelope tended to be higher in LD compared to
VD muscles.
In conclusion, the clinical picture of CP is marked
by heterogeneity. This emphasizes the importance of CP
research focusing on disentangling and categorizing the clinical
symptoms. A traditional clustering method is by the type of
motor impairment, the most accepted distinguishing spastic,
from dyskinetic and ataxic forms (1). Clinicians encountering
mixed patterns of motor impairment, provide a diagnosis
according to the most dominant and direct their treatment
accordingly (1). We suggest that even within those muscles
termed as spastic, deeper characterization of the reaction to
passive stretch may be clinically meaningful and help direct
treatment. Half of the muscles investigated in this small study
sample demonstrated an activation pattern during passive
stretch disparate to their original diagnosis of velocity-dependent
spasticity. It is possible that these muscles possess factors that
interact with their stretch reflex control. This possibly more
complex disorder may explain their reduced post-treatment
reaction at the muscle and joint level as well as reduced
functional adaptability. If the current results are validated
in larger studies, alternative treatments and closer follow-
up may be more desirable than BoNT-A in children with
LD muscles.
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